logo-loader

Resonance Health to launch pioneering liver-iron-concentration test

Published: 06:04 21 Aug 2017 BST

liver
The beta-version will be refined and evaluated across multiple centres

Resonance Health Ltd (ASX:RHT) is commencing beta-testing of its artificial intelligence (AI) solution for the low-cost analysis of liver-iron-concentration that runs off the flagship FerriScan® protocol.

The company’s FerriScan® technology provides an accurate measurement of liver iron concentration through a non-invasive, MRI-based technology.

This in situ beta testing will focus on evaluating the user-interface and usability of the new cloud-based AI service alongside FerriScan over a 30-day period.

Estimated 330,000 people born with haemoglobin disorders every year

Importantly, field testing of the first iteration of its cloud-based solution represents a significant milestone for Resonance as part of its strategy to increase market share in emerging growth markets.

Following the initial testing, the beta-version will be refined and evaluated across multiple centres, the company said.

This is scheduled to commence in the September quarter as Resonance matures the product for commercial release.

The new AI tool will have application for Thalassemia patients who are over-represented in emerging growth markets.

The World Health Organisation estimates that 330,000 people are born annually with haemoglobin disorders.

FerriScan remains the only FDA cleared method for the MRI assessment of liver-iron-concentration.

Subject to successful beta testing, Resonance Health intends to leverage the cost-effectiveness of the tool to position it as the solution of choice in measuring liver iron concentration in emerging markets.

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

30 minutes ago